Abbott Laboratories May Buy Certain Assets of Johnson & Johnson in Pakistan

Abbot Laboratories Group is presently evaluating an asset purchase transaction, whereby, it may acquire certain assets of Johnson & Johnson in Pakistan, market sources told The News on Thursday. Johnson & Johnson is for sale in Pakistan and Abbot along with Organon Bio Sciences (OBS) is left in the race for this proposed acquisition. Sources said that ICI and Pfizer were also in the competition but both the multinationals have now stepped back.

Help employers find you! Check out all the jobs and post your resume.